Log in to save to my catalogue

Synthesis and Testing of Analogs of the Tuberculosis Drug SQ109 Against Bacteria and Protozoa: Ident...

Synthesis and Testing of Analogs of the Tuberculosis Drug SQ109 Against Bacteria and Protozoa: Ident...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2730387254

Synthesis and Testing of Analogs of the Tuberculosis Drug SQ109 Against Bacteria and Protozoa: Identification of Lead Compounds Against Mycobacterium abscessus and Malaria

Publication information

Publisher

Washington: American Chemical Society

More information

Scope and Contents

Contents

SQ109 is a tuberculosis drug candidate that has high potency against Mycobacterium tuberculosis and is thought to function at least in part by blocking cell wall biosynthesis by inhibiting the MmpL3 transporter. It also has activity against bacteria and protozoan parasites that lack MmpL3, where it can act as an uncoupler, targeting lipid membranes...

Alternative Titles

Full title

Synthesis and Testing of Analogs of the Tuberculosis Drug SQ109 Against Bacteria and Protozoa: Identification of Lead Compounds Against Mycobacterium abscessus and Malaria

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2730387254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2730387254

Other Identifiers

E-ISSN

2573-2293

DOI

10.26434/chemrxiv-2022-xm94p

How to access this item